Global Supplement CDMO Market 2026 by Company, Regions, Type and Application, Forecast to 2032

September 2026 | 154 pages | ID: G4B2FCAC2F38EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Supplement CDMO market size was valued at US$ 38858 million in 2025 and is forecast to a readjusted size of US$ 59586 million by 2032 with a CAGR of 6.3% during review period.

Supplement CDMO refers to a professional organization that provides one-stop outsourcing services such as R&D, formula optimization, clinical trial support, large-scale production and packaging for health products (such as dietary supplements, functional foods, nutritional preparations, etc.). This model helps brands reduce R&D investment, accelerate product launch, and meet compliance requirements in the global market.

The outlook for the dietary supplement CDMO industry is generally positive, driven by sustained global demand for dietary supplements, functional foods, sports nutrition, healthy aging solutions, and personalized nutrition. To reduce capital investment in in-house production lines and shorten time-to-market for new products—while also navigating complex requirements such as formulation development, raw material screening, stability testing, regulatory compliance, and multi-dosage form manufacturing—brand owners are increasingly outsourcing R&D, pilot production, large-scale manufacturing, and packaging services to specialized CDMOs. Future industry growth will be increasingly concentrated in high-value-added segments—including softgels, hard capsules, tablets, powders, gummies, liquids, and complex dosage forms—alongside continued market expansion for products based on plant extracts, probiotics, proteins, vitamins and minerals, and functional active ingredients. As markets in the US, Europe, and Asia raise standards for quality traceability, GMP certification, clean-label attributes, and supply chain transparency, large-scale CDMOs possessing robust R&D capabilities, regulatory support, mass production capacity, and global supply chain networks are poised to capture greater market share; the industry is also trending toward increased specialization, economies of scale, and accelerated M&A activity.

Report Scope

This report is a detailed and comprehensive analysis for global Supplement CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Supplement CDMO market size and forecasts, in consumption value ($ Million), 2021-2032

Global Supplement CDMO market size and forecasts by region and country, in consumption value ($ Million), 2021-2032

Global Supplement CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032

Global Supplement CDMO market shares of main players, in revenue ($ Million), 2021-2026

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Supplement CDMO
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace
This report profiles key players in the global Supplement CDMO market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biofarma Group, SFI Health Solutions, TCI Bio, Lonza, HERMES PHARMA, Vitaquest, Catalent, KD Pharma Group, Pharma Tech Industries, Pierre Fabre, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Supplement CDMO market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Market segment by Type

  • ?Small Molecule CDMO?
  • ?Large Molecule CDMO?

Market segment by Product Dosage Forms

  • Capsule Supplement CDMO
  • Tablet Supplement CDMO
  • Powder Supplement CDMO
  • Liquid Supplement CDMO
  • Others

Market segment by Production Models

  • Custom Formulation
  • Ready-made Formulation
  • Custom + Ready-made Formulation

Market segment by Application

  • Sports Nutrition (Protein Powder, Amino Acids, Creatine, Electrolytes, etc.)
  • Digestive Health (Probiotics, Prebiotics, Digestive Enzymes, Dietary Fiber, etc.)
  • Immune Health (Vitamin C, Zinc, Elderberry, Immune Support Blends, etc.)
  • Bone & Joint Health (Calcium, Glucosamine, Chondroitin, Collagen, etc.)
  • Cardiovascular Health (Fish Oil, Omega-3, CoQ10, Plant Sterols, etc.)
  • Beauty & Wellness (Collagen, Biotin, Beauty Gummies, etc.)
  • Sleep & Mood Health (Melatonin, Magnesium, Theanine, etc.)
  • Others

Market segment by players, this report covers

  • Biofarma Group
  • SFI Health Solutions
  • TCI Bio
  • Lonza
  • HERMES PHARMA
  • Vitaquest
  • Catalent
  • KD Pharma Group
  • Pharma Tech Industries
  • Pierre Fabre
  • NutraPak USA
  • American Health Formulations
  • Aenova Group
  • Robinson Pharma
  • CAPTEK Softgel International
  • Makers Nutrition
  • Goerlich Pharma
  • API Co., Ltd
  • Kolmar BNH
  • COSMAX BIO
  • NOVAREX
  • ORi Bionature
  • Sirio Pharma
  • Baihe Biotech

Market segment by regions, regional analysis covers

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
  • South America (Brazil, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Chapter Outline

Chapter 1, to describe Supplement CDMO product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Supplement CDMO, with revenue, gross margin, and global market share of Supplement CDMO from 2021 to 2026.

Chapter 3, the Supplement CDMO competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Supplement CDMO market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Supplement CDMO.

Chapter 13, to describe Supplement CDMO research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Supplement CDMO by Type
  1.3.1 Overview: Global Supplement CDMO Market Size by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Global Supplement CDMO Consumption Value Market Share by Type in 2025
  1.3.3 ?Small Molecule CDMO?
  1.3.4 ?Large Molecule CDMO?
1.4 Classification of Supplement CDMO by Product Dosage Forms
  1.4.1 Overview: Global Supplement CDMO Market Size by Product Dosage Forms: 2021 Versus 2025 Versus 2032
  1.4.2 Global Supplement CDMO Consumption Value Market Share by Product Dosage Forms in 2025
  1.4.3 Capsule Supplement CDMO
  1.4.4 Tablet Supplement CDMO
  1.4.5 Powder Supplement CDMO
  1.4.6 Liquid Supplement CDMO
  1.4.7 Others
1.5 Classification of Supplement CDMO by Production Models
  1.5.1 Overview: Global Supplement CDMO Market Size by Production Models: 2021 Versus 2025 Versus 2032
  1.5.2 Global Supplement CDMO Consumption Value Market Share by Production Models in 2025
  1.5.3 Custom Formulation
  1.5.4 Ready-made Formulation
  1.5.5 Custom + Ready-made Formulation
1.6 Global Supplement CDMO Market by Application
  1.6.1 Overview: Global Supplement CDMO Market Size by Application: 2021 Versus 2025 Versus 2032
  1.6.2 Sports Nutrition (Protein Powder, Amino Acids, Creatine, Electrolytes, etc.)
  1.6.3 Digestive Health (Probiotics, Prebiotics, Digestive Enzymes, Dietary Fiber, etc.)
  1.6.4 Immune Health (Vitamin C, Zinc, Elderberry, Immune Support Blends, etc.)
  1.6.5 Bone & Joint Health (Calcium, Glucosamine, Chondroitin, Collagen, etc.)
  1.6.6 Cardiovascular Health (Fish Oil, Omega-3, CoQ10, Plant Sterols, etc.)
  1.6.7 Beauty & Wellness (Collagen, Biotin, Beauty Gummies, etc.)
  1.6.8 Sleep & Mood Health (Melatonin, Magnesium, Theanine, etc.)
  1.6.9 Others
1.7 Global Supplement CDMO Market Size & Forecast
1.8 Global Supplement CDMO Market Size and Forecast by Region
  1.8.1 Global Supplement CDMO Market Size by Region: 2021 VS 2025 VS 2032
  1.8.2 Global Supplement CDMO Market Size by Region, (2021-2032)
  1.8.3 North America Supplement CDMO Market Size and Prospect (2021-2032)
  1.8.4 Europe Supplement CDMO Market Size and Prospect (2021-2032)
  1.8.5 Asia-Pacific Supplement CDMO Market Size and Prospect (2021-2032)
  1.8.6 South America Supplement CDMO Market Size and Prospect (2021-2032)
  1.8.7 Middle East & Africa Supplement CDMO Market Size and Prospect (2021-2032)

2 COMPANY PROFILES

2.1 Biofarma Group
  2.1.1 Biofarma Group Details
  2.1.2 Biofarma Group Major Business
  2.1.3 Biofarma Group Supplement CDMO Product and Solutions
  2.1.4 Biofarma Group Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 Biofarma Group Recent Developments and Future Plans
2.2 SFI Health Solutions
  2.2.1 SFI Health Solutions Details
  2.2.2 SFI Health Solutions Major Business
  2.2.3 SFI Health Solutions Supplement CDMO Product and Solutions
  2.2.4 SFI Health Solutions Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 SFI Health Solutions Recent Developments and Future Plans
2.3 TCI Bio
  2.3.1 TCI Bio Details
  2.3.2 TCI Bio Major Business
  2.3.3 TCI Bio Supplement CDMO Product and Solutions
  2.3.4 TCI Bio Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 TCI Bio Recent Developments and Future Plans
2.4 Lonza
  2.4.1 Lonza Details
  2.4.2 Lonza Major Business
  2.4.3 Lonza Supplement CDMO Product and Solutions
  2.4.4 Lonza Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 Lonza Recent Developments and Future Plans
2.5 HERMES PHARMA
  2.5.1 HERMES PHARMA Details
  2.5.2 HERMES PHARMA Major Business
  2.5.3 HERMES PHARMA Supplement CDMO Product and Solutions
  2.5.4 HERMES PHARMA Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 HERMES PHARMA Recent Developments and Future Plans
2.6 Vitaquest
  2.6.1 Vitaquest Details
  2.6.2 Vitaquest Major Business
  2.6.3 Vitaquest Supplement CDMO Product and Solutions
  2.6.4 Vitaquest Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 Vitaquest Recent Developments and Future Plans
2.7 Catalent
  2.7.1 Catalent Details
  2.7.2 Catalent Major Business
  2.7.3 Catalent Supplement CDMO Product and Solutions
  2.7.4 Catalent Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 Catalent Recent Developments and Future Plans
2.8 KD Pharma Group
  2.8.1 KD Pharma Group Details
  2.8.2 KD Pharma Group Major Business
  2.8.3 KD Pharma Group Supplement CDMO Product and Solutions
  2.8.4 KD Pharma Group Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.8.5 KD Pharma Group Recent Developments and Future Plans
2.9 Pharma Tech Industries
  2.9.1 Pharma Tech Industries Details
  2.9.2 Pharma Tech Industries Major Business
  2.9.3 Pharma Tech Industries Supplement CDMO Product and Solutions
  2.9.4 Pharma Tech Industries Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.9.5 Pharma Tech Industries Recent Developments and Future Plans
2.10 Pierre Fabre
  2.10.1 Pierre Fabre Details
  2.10.2 Pierre Fabre Major Business
  2.10.3 Pierre Fabre Supplement CDMO Product and Solutions
  2.10.4 Pierre Fabre Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.10.5 Pierre Fabre Recent Developments and Future Plans
2.11 NutraPak USA
  2.11.1 NutraPak USA Details
  2.11.2 NutraPak USA Major Business
  2.11.3 NutraPak USA Supplement CDMO Product and Solutions
  2.11.4 NutraPak USA Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.11.5 NutraPak USA Recent Developments and Future Plans
2.12 American Health Formulations
  2.12.1 American Health Formulations Details
  2.12.2 American Health Formulations Major Business
  2.12.3 American Health Formulations Supplement CDMO Product and Solutions
  2.12.4 American Health Formulations Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.12.5 American Health Formulations Recent Developments and Future Plans
2.13 Aenova Group
  2.13.1 Aenova Group Details
  2.13.2 Aenova Group Major Business
  2.13.3 Aenova Group Supplement CDMO Product and Solutions
  2.13.4 Aenova Group Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.13.5 Aenova Group Recent Developments and Future Plans
2.14 Robinson Pharma
  2.14.1 Robinson Pharma Details
  2.14.2 Robinson Pharma Major Business
  2.14.3 Robinson Pharma Supplement CDMO Product and Solutions
  2.14.4 Robinson Pharma Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.14.5 Robinson Pharma Recent Developments and Future Plans
2.15 CAPTEK Softgel International
  2.15.1 CAPTEK Softgel International Details
  2.15.2 CAPTEK Softgel International Major Business
  2.15.3 CAPTEK Softgel International Supplement CDMO Product and Solutions
  2.15.4 CAPTEK Softgel International Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.15.5 CAPTEK Softgel International Recent Developments and Future Plans
2.16 Makers Nutrition
  2.16.1 Makers Nutrition Details
  2.16.2 Makers Nutrition Major Business
  2.16.3 Makers Nutrition Supplement CDMO Product and Solutions
  2.16.4 Makers Nutrition Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.16.5 Makers Nutrition Recent Developments and Future Plans
2.17 Goerlich Pharma
  2.17.1 Goerlich Pharma Details
  2.17.2 Goerlich Pharma Major Business
  2.17.3 Goerlich Pharma Supplement CDMO Product and Solutions
  2.17.4 Goerlich Pharma Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.17.5 Goerlich Pharma Recent Developments and Future Plans
2.18 API Co., Ltd
  2.18.1 API Co., Ltd Details
  2.18.2 API Co., Ltd Major Business
  2.18.3 API Co., Ltd Supplement CDMO Product and Solutions
  2.18.4 API Co., Ltd Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.18.5 API Co., Ltd Recent Developments and Future Plans
2.19 Kolmar BNH
  2.19.1 Kolmar BNH Details
  2.19.2 Kolmar BNH Major Business
  2.19.3 Kolmar BNH Supplement CDMO Product and Solutions
  2.19.4 Kolmar BNH Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.19.5 Kolmar BNH Recent Developments and Future Plans
2.20 COSMAX BIO
  2.20.1 COSMAX BIO Details
  2.20.2 COSMAX BIO Major Business
  2.20.3 COSMAX BIO Supplement CDMO Product and Solutions
  2.20.4 COSMAX BIO Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.20.5 COSMAX BIO Recent Developments and Future Plans
2.21 NOVAREX
  2.21.1 NOVAREX Details
  2.21.2 NOVAREX Major Business
  2.21.3 NOVAREX Supplement CDMO Product and Solutions
  2.21.4 NOVAREX Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.21.5 NOVAREX Recent Developments and Future Plans
2.22 ORi Bionature
  2.22.1 ORi Bionature Details
  2.22.2 ORi Bionature Major Business
  2.22.3 ORi Bionature Supplement CDMO Product and Solutions
  2.22.4 ORi Bionature Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.22.5 ORi Bionature Recent Developments and Future Plans
2.23 Sirio Pharma
  2.23.1 Sirio Pharma Details
  2.23.2 Sirio Pharma Major Business
  2.23.3 Sirio Pharma Supplement CDMO Product and Solutions
  2.23.4 Sirio Pharma Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.23.5 Sirio Pharma Recent Developments and Future Plans
2.24 Baihe Biotech
  2.24.1 Baihe Biotech Details
  2.24.2 Baihe Biotech Major Business
  2.24.3 Baihe Biotech Supplement CDMO Product and Solutions
  2.24.4 Baihe Biotech Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
  2.24.5 Baihe Biotech Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Supplement CDMO Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
  3.2.1 Market Share of Supplement CDMO by Company Revenue
  3.2.2 Top 3 Supplement CDMO Players Market Share in 2025
  3.2.3 Top 6 Supplement CDMO Players Market Share in 2025
3.3 Supplement CDMO Market: Overall Company Footprint Analysis
  3.3.1 Supplement CDMO Market: Region Footprint
  3.3.2 Supplement CDMO Market: Company Product Type Footprint
  3.3.3 Supplement CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Supplement CDMO Consumption Value and Market Share by Type (2021-2026)
4.2 Global Supplement CDMO Market Forecast by Type (2027-2032)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Supplement CDMO Consumption Value Market Share by Application (2021-2026)
5.2 Global Supplement CDMO Market Forecast by Application (2027-2032)

6 NORTH AMERICA

6.1 North America Supplement CDMO Consumption Value by Type (2021-2032)
6.2 North America Supplement CDMO Market Size by Application (2021-2032)
6.3 North America Supplement CDMO Market Size by Country
  6.3.1 North America Supplement CDMO Consumption Value by Country (2021-2032)
  6.3.2 United States Supplement CDMO Market Size and Forecast (2021-2032)
  6.3.3 Canada Supplement CDMO Market Size and Forecast (2021-2032)
  6.3.4 Mexico Supplement CDMO Market Size and Forecast (2021-2032)

7 EUROPE

7.1 Europe Supplement CDMO Consumption Value by Type (2021-2032)
7.2 Europe Supplement CDMO Consumption Value by Application (2021-2032)
7.3 Europe Supplement CDMO Market Size by Country
  7.3.1 Europe Supplement CDMO Consumption Value by Country (2021-2032)
  7.3.2 Germany Supplement CDMO Market Size and Forecast (2021-2032)
  7.3.3 France Supplement CDMO Market Size and Forecast (2021-2032)
  7.3.4 United Kingdom Supplement CDMO Market Size and Forecast (2021-2032)
  7.3.5 Russia Supplement CDMO Market Size and Forecast (2021-2032)
  7.3.6 Italy Supplement CDMO Market Size and Forecast (2021-2032)

8 ASIA-PACIFIC

8.1 Asia-Pacific Supplement CDMO Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Supplement CDMO Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Supplement CDMO Market Size by Region
  8.3.1 Asia-Pacific Supplement CDMO Consumption Value by Region (2021-2032)
  8.3.2 China Supplement CDMO Market Size and Forecast (2021-2032)
  8.3.3 Japan Supplement CDMO Market Size and Forecast (2021-2032)
  8.3.4 South Korea Supplement CDMO Market Size and Forecast (2021-2032)
  8.3.5 India Supplement CDMO Market Size and Forecast (2021-2032)
  8.3.6 Southeast Asia Supplement CDMO Market Size and Forecast (2021-2032)
  8.3.7 Australia Supplement CDMO Market Size and Forecast (2021-2032)

9 SOUTH AMERICA

9.1 South America Supplement CDMO Consumption Value by Type (2021-2032)
9.2 South America Supplement CDMO Consumption Value by Application (2021-2032)
9.3 South America Supplement CDMO Market Size by Country
  9.3.1 South America Supplement CDMO Consumption Value by Country (2021-2032)
  9.3.2 Brazil Supplement CDMO Market Size and Forecast (2021-2032)
  9.3.3 Argentina Supplement CDMO Market Size and Forecast (2021-2032)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Supplement CDMO Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Supplement CDMO Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Supplement CDMO Market Size by Country
  10.3.1 Middle East & Africa Supplement CDMO Consumption Value by Country (2021-2032)
  10.3.2 Turkey Supplement CDMO Market Size and Forecast (2021-2032)
  10.3.3 Saudi Arabia Supplement CDMO Market Size and Forecast (2021-2032)
  10.3.4 UAE Supplement CDMO Market Size and Forecast (2021-2032)

11 MARKET DYNAMICS

11.1 Supplement CDMO Market Drivers
11.2 Supplement CDMO Market Restraints
11.3 Supplement CDMO Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Supplement CDMO Industry Chain
12.2 Supplement CDMO Upstream Analysis
12.3 Supplement CDMO Midstream Analysis
12.4 Supplement CDMO Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES

Table 1. Global Supplement CDMO Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Supplement CDMO Consumption Value by Product Dosage Forms, (USD Million), 2021 & 2025 & 2032
Table 3. Global Supplement CDMO Consumption Value by Production Models, (USD Million), 2021 & 2025 & 2032
Table 4. Global Supplement CDMO Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Supplement CDMO Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Supplement CDMO Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Biofarma Group Company Information, Head Office, and Major Competitors
Table 8. Biofarma Group Major Business
Table 9. Biofarma Group Supplement CDMO Product and Solutions
Table 10. Biofarma Group Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Biofarma Group Recent Developments and Future Plans
Table 12. SFI Health Solutions Company Information, Head Office, and Major Competitors
Table 13. SFI Health Solutions Major Business
Table 14. SFI Health Solutions Supplement CDMO Product and Solutions
Table 15. SFI Health Solutions Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. SFI Health Solutions Recent Developments and Future Plans
Table 17. TCI Bio Company Information, Head Office, and Major Competitors
Table 18. TCI Bio Major Business
Table 19. TCI Bio Supplement CDMO Product and Solutions
Table 20. TCI Bio Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Lonza Company Information, Head Office, and Major Competitors
Table 22. Lonza Major Business
Table 23. Lonza Supplement CDMO Product and Solutions
Table 24. Lonza Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Lonza Recent Developments and Future Plans
Table 26. HERMES PHARMA Company Information, Head Office, and Major Competitors
Table 27. HERMES PHARMA Major Business
Table 28. HERMES PHARMA Supplement CDMO Product and Solutions
Table 29. HERMES PHARMA Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. HERMES PHARMA Recent Developments and Future Plans
Table 31. Vitaquest Company Information, Head Office, and Major Competitors
Table 32. Vitaquest Major Business
Table 33. Vitaquest Supplement CDMO Product and Solutions
Table 34. Vitaquest Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Vitaquest Recent Developments and Future Plans
Table 36. Catalent Company Information, Head Office, and Major Competitors
Table 37. Catalent Major Business
Table 38. Catalent Supplement CDMO Product and Solutions
Table 39. Catalent Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Catalent Recent Developments and Future Plans
Table 41. KD Pharma Group Company Information, Head Office, and Major Competitors
Table 42. KD Pharma Group Major Business
Table 43. KD Pharma Group Supplement CDMO Product and Solutions
Table 44. KD Pharma Group Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. KD Pharma Group Recent Developments and Future Plans
Table 46. Pharma Tech Industries Company Information, Head Office, and Major Competitors
Table 47. Pharma Tech Industries Major Business
Table 48. Pharma Tech Industries Supplement CDMO Product and Solutions
Table 49. Pharma Tech Industries Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Pharma Tech Industries Recent Developments and Future Plans
Table 51. Pierre Fabre Company Information, Head Office, and Major Competitors
Table 52. Pierre Fabre Major Business
Table 53. Pierre Fabre Supplement CDMO Product and Solutions
Table 54. Pierre Fabre Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Pierre Fabre Recent Developments and Future Plans
Table 56. NutraPak USA Company Information, Head Office, and Major Competitors
Table 57. NutraPak USA Major Business
Table 58. NutraPak USA Supplement CDMO Product and Solutions
Table 59. NutraPak USA Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. NutraPak USA Recent Developments and Future Plans
Table 61. American Health Formulations Company Information, Head Office, and Major Competitors
Table 62. American Health Formulations Major Business
Table 63. American Health Formulations Supplement CDMO Product and Solutions
Table 64. American Health Formulations Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. American Health Formulations Recent Developments and Future Plans
Table 66. Aenova Group Company Information, Head Office, and Major Competitors
Table 67. Aenova Group Major Business
Table 68. Aenova Group Supplement CDMO Product and Solutions
Table 69. Aenova Group Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Aenova Group Recent Developments and Future Plans
Table 71. Robinson Pharma Company Information, Head Office, and Major Competitors
Table 72. Robinson Pharma Major Business
Table 73. Robinson Pharma Supplement CDMO Product and Solutions
Table 74. Robinson Pharma Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Robinson Pharma Recent Developments and Future Plans
Table 76. CAPTEK Softgel International Company Information, Head Office, and Major Competitors
Table 77. CAPTEK Softgel International Major Business
Table 78. CAPTEK Softgel International Supplement CDMO Product and Solutions
Table 79. CAPTEK Softgel International Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. CAPTEK Softgel International Recent Developments and Future Plans
Table 81. Makers Nutrition Company Information, Head Office, and Major Competitors
Table 82. Makers Nutrition Major Business
Table 83. Makers Nutrition Supplement CDMO Product and Solutions
Table 84. Makers Nutrition Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Makers Nutrition Recent Developments and Future Plans
Table 86. Goerlich Pharma Company Information, Head Office, and Major Competitors
Table 87. Goerlich Pharma Major Business
Table 88. Goerlich Pharma Supplement CDMO Product and Solutions
Table 89. Goerlich Pharma Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Goerlich Pharma Recent Developments and Future Plans
Table 91. API Co., Ltd Company Information, Head Office, and Major Competitors
Table 92. API Co., Ltd Major Business
Table 93. API Co., Ltd Supplement CDMO Product and Solutions
Table 94. API Co., Ltd Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. API Co., Ltd Recent Developments and Future Plans
Table 96. Kolmar BNH Company Information, Head Office, and Major Competitors
Table 97. Kolmar BNH Major Business
Table 98. Kolmar BNH Supplement CDMO Product and Solutions
Table 99. Kolmar BNH Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Kolmar BNH Recent Developments and Future Plans
Table 101. COSMAX BIO Company Information, Head Office, and Major Competitors
Table 102. COSMAX BIO Major Business
Table 103. COSMAX BIO Supplement CDMO Product and Solutions
Table 104. COSMAX BIO Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. COSMAX BIO Recent Developments and Future Plans
Table 106. NOVAREX Company Information, Head Office, and Major Competitors
Table 107. NOVAREX Major Business
Table 108. NOVAREX Supplement CDMO Product and Solutions
Table 109. NOVAREX Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. NOVAREX Recent Developments and Future Plans
Table 111. ORi Bionature Company Information, Head Office, and Major Competitors
Table 112. ORi Bionature Major Business
Table 113. ORi Bionature Supplement CDMO Product and Solutions
Table 114. ORi Bionature Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. ORi Bionature Recent Developments and Future Plans
Table 116. Sirio Pharma Company Information, Head Office, and Major Competitors
Table 117. Sirio Pharma Major Business
Table 118. Sirio Pharma Supplement CDMO Product and Solutions
Table 119. Sirio Pharma Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Sirio Pharma Recent Developments and Future Plans
Table 121. Baihe Biotech Company Information, Head Office, and Major Competitors
Table 122. Baihe Biotech Major Business
Table 123. Baihe Biotech Supplement CDMO Product and Solutions
Table 124. Baihe Biotech Supplement CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Baihe Biotech Recent Developments and Future Plans
Table 126. Global Supplement CDMO Revenue (USD Million) by Players (2021-2026)
Table 127. Global Supplement CDMO Revenue Share by Players (2021-2026)
Table 128. Breakdown of Supplement CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 129. Market Position of Players in Supplement CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 130. Head Office of Key Supplement CDMO Players
Table 131. Supplement CDMO Market: Company Product Type Footprint
Table 132. Supplement CDMO Market: Company Product Application Footprint
Table 133. Supplement CDMO New Market Entrants and Barriers to Market Entry
Table 134. Supplement CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 135. Global Supplement CDMO Consumption Value (USD Million) by Type (2021-2026)
Table 136. Global Supplement CDMO Consumption Value Share by Type (2021-2026)
Table 137. Global Supplement CDMO Consumption Value Forecast by Type (2027-2032)
Table 138. Global Supplement CDMO Consumption Value by Application (2021-2026)
Table 139. Global Supplement CDMO Consumption Value Forecast by Application (2027-2032)
Table 140. North America Supplement CDMO Consumption Value by Type (2021-2026) & (USD Million)
Table 141. North America Supplement CDMO Consumption Value by Type (2027-2032) & (USD Million)
Table 142. North America Supplement CDMO Consumption Value by Application (2021-2026) & (USD Million)
Table 143. North America Supplement CDMO Consumption Value by Application (2027-2032) & (USD Million)
Table 144. North America Supplement CDMO Consumption Value by Country (2021-2026) & (USD Million)
Table 145. North America Supplement CDMO Consumption Value by Country (2027-2032) & (USD Million)
Table 146. Europe Supplement CDMO Consumption Value by Type (2021-2026) & (USD Million)
Table 147. Europe Supplement CDMO Consumption Value by Type (2027-2032) & (USD Million)
Table 148. Europe Supplement CDMO Consumption Value by Application (2021-2026) & (USD Million)
Table 149. Europe Supplement CDMO Consumption Value by Application (2027-2032) & (USD Million)
Table 150. Europe Supplement CDMO Consumption Value by Country (2021-2026) & (USD Million)
Table 151. Europe Supplement CDMO Consumption Value by Country (2027-2032) & (USD Million)
Table 152. Asia-Pacific Supplement CDMO Consumption Value by Type (2021-2026) & (USD Million)
Table 153. Asia-Pacific Supplement CDMO Consumption Value by Type (2027-2032) & (USD Million)
Table 154. Asia-Pacific Supplement CDMO Consumption Value by Application (2021-2026) & (USD Million)
Table 155. Asia-Pacific Supplement CDMO Consumption Value by Application (2027-2032) & (USD Million)
Table 156. Asia-Pacific Supplement CDMO Consumption Value by Region (2021-2026) & (USD Million)
Table 157. Asia-Pacific Supplement CDMO Consumption Value by Region (2027-2032) & (USD Million)
Table 158. South America Supplement CDMO Consumption Value by Type (2021-2026) & (USD Million)
Table 159. South America Supplement CDMO Consumption Value by Type (2027-2032) & (USD Million)
Table 160. South America Supplement CDMO Consumption Value by Application (2021-2026) & (USD Million)
Table 161. South America Supplement CDMO Consumption Value by Application (2027-2032) & (USD Million)
Table 162. South America Supplement CDMO Consumption Value by Country (2021-2026) & (USD Million)
Table 163. South America Supplement CDMO Consumption Value by Country (2027-2032) & (USD Million)
Table 164. Middle East & Africa Supplement CDMO Consumption Value by Type (2021-2026) & (USD Million)
Table 165. Middle East & Africa Supplement CDMO Consumption Value by Type (2027-2032) & (USD Million)
Table 166. Middle East & Africa Supplement CDMO Consumption Value by Application (2021-2026) & (USD Million)
Table 167. Middle East & Africa Supplement CDMO Consumption Value by Application (2027-2032) & (USD Million)
Table 168. Middle East & Africa Supplement CDMO Consumption Value by Country (2021-2026) & (USD Million)
Table 169. Middle East & Africa Supplement CDMO Consumption Value by Country (2027-2032) & (USD Million)
Table 170. Global Key Players of Supplement CDMO Upstream (Raw Materials)
Table 171. Global Supplement CDMO Typical Customers

LIST OF FIGURES

Figure 1. Supplement CDMO Picture
Figure 2. Global Supplement CDMO Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Supplement CDMO Consumption Value Market Share by Type in 2025
Figure 4. ?Small Molecule CDMO?
Figure 5. ?Large Molecule CDMO?
Figure 6. Global Supplement CDMO Consumption Value by Product Dosage Forms, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Supplement CDMO Consumption Value Market Share by Product Dosage Forms in 2025
Figure 8. Capsule Supplement CDMO
Figure 9. Tablet Supplement CDMO
Figure 10. Powder Supplement CDMO
Figure 11. Liquid Supplement CDMO
Figure 12. Others
Figure 13. Global Supplement CDMO Consumption Value by Production Models, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Supplement CDMO Consumption Value Market Share by Production Models in 2025
Figure 15. Custom Formulation
Figure 16. Ready-made Formulation
Figure 17. Custom + Ready-made Formulation
Figure 18. Global Supplement CDMO Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Supplement CDMO Consumption Value Market Share by Application in 2025
Figure 20. Sports Nutrition (Protein Powder, Amino Acids, Creatine, Electrolytes, etc.) Picture
Figure 21. Digestive Health (Probiotics, Prebiotics, Digestive Enzymes, Dietary Fiber, etc.) Picture
Figure 22. Immune Health (Vitamin C, Zinc, Elderberry, Immune Support Blends, etc.) Picture
Figure 23. Bone & Joint Health (Calcium, Glucosamine, Chondroitin, Collagen, etc.) Picture
Figure 24. Cardiovascular Health (Fish Oil, Omega-3, CoQ10, Plant Sterols, etc.) Picture
Figure 25. Beauty & Wellness (Collagen, Biotin, Beauty Gummies, etc.) Picture
Figure 26. Sleep & Mood Health (Melatonin, Magnesium, Theanine, etc.) Picture
Figure 27. Others Picture
Figure 28. Global Supplement CDMO Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 29. Global Supplement CDMO Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 30. Global Market Supplement CDMO Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 31. Global Supplement CDMO Consumption Value Market Share by Region (2021-2032)
Figure 32. Global Supplement CDMO Consumption Value Market Share by Region in 2025
Figure 33. North America Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 34. Europe Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 35. Asia-Pacific Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 36. South America Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 37. Middle East & Africa Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 38. Company Three Recent Developments and Future Plans
Figure 39. Global Supplement CDMO Revenue Share by Players in 2025
Figure 40. Supplement CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 41. Market Share of Supplement CDMO by Player Revenue in 2025
Figure 42. Top 3 Supplement CDMO Players Market Share in 2025
Figure 43. Top 6 Supplement CDMO Players Market Share in 2025
Figure 44. Global Supplement CDMO Consumption Value Share by Type (2021-2026)
Figure 45. Global Supplement CDMO Market Share Forecast by Type (2027-2032)
Figure 46. Global Supplement CDMO Consumption Value Share by Application (2021-2026)
Figure 47. Global Supplement CDMO Market Share Forecast by Application (2027-2032)
Figure 48. North America Supplement CDMO Consumption Value Market Share by Type (2021-2032)
Figure 49. North America Supplement CDMO Consumption Value Market Share by Application (2021-2032)
Figure 50. North America Supplement CDMO Consumption Value Market Share by Country (2021-2032)
Figure 51. United States Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 52. Canada Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 53. Mexico Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 54. Europe Supplement CDMO Consumption Value Market Share by Type (2021-2032)
Figure 55. Europe Supplement CDMO Consumption Value Market Share by Application (2021-2032)
Figure 56. Europe Supplement CDMO Consumption Value Market Share by Country (2021-2032)
Figure 57. Germany Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 58. France Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 59. United Kingdom Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 60. Russia Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 61. Italy Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 62. Asia-Pacific Supplement CDMO Consumption Value Market Share by Type (2021-2032)
Figure 63. Asia-Pacific Supplement CDMO Consumption Value Market Share by Application (2021-2032)
Figure 64. Asia-Pacific Supplement CDMO Consumption Value Market Share by Region (2021-2032)
Figure 65. China Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 66. Japan Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 67. South Korea Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 68. India Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 69. Southeast Asia Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 70. Australia Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 71. South America Supplement CDMO Consumption Value Market Share by Type (2021-2032)
Figure 72. South America Supplement CDMO Consumption Value Market Share by Application (2021-2032)
Figure 73. South America Supplement CDMO Consumption Value Market Share by Country (2021-2032)
Figure 74. Brazil Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 75. Argentina Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 76. Middle East & Africa Supplement CDMO Consumption Value Market Share by Type (2021-2032)
Figure 77. Middle East & Africa Supplement CDMO Consumption Value Market Share by Application (2021-2032)
Figure 78. Middle East & Africa Supplement CDMO Consumption Value Market Share by Country (2021-2032)
Figure 79. Turkey Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 80. Saudi Arabia Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 81. UAE Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 82. Supplement CDMO Market Drivers
Figure 83. Supplement CDMO Market Restraints
Figure 84. Supplement CDMO Market Trends
Figure 85. Porters Five Forces Analysis
Figure 86. Supplement CDMO Industrial Chain
Figure 87. Methodology
Figure 88. Research Process and Data Source